Share Facebook Twitter LinkedIn Pinterest Email Bausch health outlines 2025 guidance with 4-5% revenue and EBITDA growth amid strategic refinancing
Asian markets mixed as technology selloff lifts Wall Street volatility (EWJ:NYSEARCA)October 19, 2026